Prometheus 2.0: drug-induced liver regeneration arising  

作　　者：Jan S.Tchorz 

机构地区：[1]Biomedical Research,Novartis Pharma AG,Basel,Switzerland

出　　处：《Cell Research》2024年第8期541-542,共2页细胞研究（英文版）

摘　　要：In a recent publication in Cell,a multidisciplinary academic drug discovery team,with its spin-off HepaRegeniX,published a first-in-class small molecule MKK4 inhibitor(HRX215)with remarkable efficacy in multiple preclinical liver regeneration models and positive first-in-human data.Its potential to prevent liver failure and boost regeneration may provide a novel therapeutic avenue for many patients with liver disease.

关 键 词：DRUG LIVER CLINICAL 

分 类 号：R57[医药卫生—消化系统]